Introduction
Traumatic brain injury (TBI) has been implicated as one of the most significant environmental risk factors for Alzheimer's disease (AD), Parkinson's disease (PD) and frontotemporal dementia (FTD). The cumulative effect of multiple brain injuries is also highlighted by the prevalence of chronic traumatic encephalopathy (CTE) in professional athletes. [1] [2] [3] [4] Key pathological features of neurodegenerative tauopathies include neuroinflammation, hyperphosphorylation and aggregation of microtubule associated protein tau (MAPT), and formation of neurofibrillary tangles (NFTs). 5 Given that a primary TBI is irreversible, increased attention has been directed toward identifying secondary injury mechanisms facilitating neurodegeneration. Axonal injury following the initial insult is proposed to be the first perturbation of MAPT as it promotes microtubule dissociation and subsequent phosphorylation and aggregation. 3, 6, 7 A robust and persistent post-injury neuroinflammatory response may then be sufficient to exacerbate tau pathology and promote neurodegeneration.
Post-injury neuroinflammation is characterized by activation of brain-resident microglia, infiltration of peripheral myeloid cells (PMCs) due to disruption of the bloodbrain-barrier (BBB), astrogliosis and increased synthesis and release of pro-and antiinflammatory molecules. 8, 9 Several observations suggest that TBI-induced neuroinflammation regulates MAPT pathologies, including hyperphosphorylation and aggregation. First, a recent set of experiments demonstrated that MAPT pathology temporally co-exists with gliosis following repetitive mTBI in the hTau mouse model of MAPT pathology. 10 Similar findings have been reported in wild-type mice after blastinduced TBI and in a triple transgenic mouse model of AD following a single moderate TBI. 2, 11 Second, numerous reports have demonstrated activated microglia near the injury release several pro-inflammatory cytokines and chemokines and that these inflammatory molecules in turn can exacerbate MAPT pathologies. 10, 12, 13 Finally, previous work from our group revealed that targeted modulation of key chemokines involved in the postinflammatory response significantly influences AD-like neuropathology following mild TBI. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
We sought to extend these findings by examining the effects of a single TBI in a
disease-relevant mouse model of tauopathy. We utilized genomic-based MAPT transgenic mice (line 8c) in a Mapt knockout background (called "hTau") that express all six isoforms of non-mutant human MAPT. Notably, the mouse brain contains only 4 repeat (4R) MAPT isoforms, but the human brain contains an equal distribution of both 3 repeat (3R) and 4R
MAPT isoforms. Naïve hTau mice display somato-dendritic MAPT redistribution at 3 months of age, MAPT hyperphosphorylation at 6 months of age, MAPT aggregation at nine-months of age, and neuronal loss by 15 months of age. Thus, the pathology in hTau mice is not completely related to an overexpression of human MAPT, but instead is a result of an altered ratio of 3R isoforms over 4R isoforms that is not present in line 8c alone. [15] [16] [17] [18] At two-months of age, hTau and C57BL/6J (B6) mice were exposed to lateral fluid percussion TBI or sham injury and examined at both acute and chronic time points. Since TBI induces microglial reactivity as well as peripheral macrophage recruitment that correlate with MAPT pathology, 2, [11] [12] [13] 19, 20 we focused our efforts on quantifying the microglial and macrophage response to TBI. We also evaluated the spatial and temporal distribution of MAPT pathology and documented behavioral changes as subjects aged. Our group has utilized these hTau mice in various recent studies and clearly demonstrated that reactive microglia are critical mediators of MAPT pathology. [21] [22] [23] [24] Notably, the microglial/macrophage response to TBI was enhanced in hTau mice compared to all other groups at 3 days post-injury (DPI) and hTau mice showed increased MAPT phosphorylation in the ipsilateral temporal cortex. Through flow cytometric analysis we identified four, unique myeloid populations that persist in the brain at 135 DPI. Based on CD45 expression we conclude that there is an overall reduction in microglial reactivity with a persistent macrophage presence in hTau TBI mice compared to other control groups, which corresponded with an increase in region-specific MAPT pathology and cognitive dysfunction. Collectively, these data show that a single TBI alters the neuroinflammatory environment, advances the appearance of age-related MAPT pathology and induces behavioral impairment in a humanized mouse-model of tauopathy; however, the mediating mechanisms in this relationship require further investigation. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Materials and Methods

Study Design
The primary objective of this study was to characterize the post-injury microglial/macrophage response to TBI at both acute and chronic time points in the presence or absence of wild-type human tau. Separate groups of hTau and B6 mice were used for acute and chronic studies. Each subject was randomized to the TBI or sham group following surgical preparation. A separate investigator blinded to experimental group performed subsequent data analysis. All subjects surviving to 3 or 135 DPI were included in data analysis and no outliers were excluded.
Mice
The hTau mouse model of tauopathy was utilized to characterize recovery following TBI. 
Surgical preparation and injury.
All surgical procedures were completed as previously described. 25 Briefly, two-month-old hTau and B6 mice were anesthetized with a combination of ketamine (100 mg/kg) and xylazine (10 mg/kg) before being placed in a stereotaxic frame. Bupivicaine (0.25%, 50 l) was delivered subcutaneously before midline incision. A 3.0 mm craniotomy was trephined over the right parietal cortex midway between bregma and lambda leaving the dura intact.
A modified Leur-Loc syringe (3.0 mm inside diameter) was placed over the exposed dura and held in place by cyanoacrylate adhesive. Mice were placed on a heating pad to recover following surgical preparation. Once animals regained normal ambulatory behavior, they were placed in their home cage overnight. Twenty-four hours after surgical preparation, all mice were anesthetized with the same combination of ketamine and xylazine and connected to the FPI device (Amscien Instruments, Richmond, VA). A moderate level FPI (M = 1.0 atmospheres of extracranial pressure) was delivered to animals in the TBI group.
Animals in the sham group were connected to the injury device; however, no fluid pulse was delivered. The syringe and adhesive were removed from the skull following FPI or This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
sham injury and the incision was sutured closed. All animals recovered on a heating pad before being placed in their home cage. Mice were sacrificed at either 3 DPI or 135 DPI (one week after completion of spatial memory testing in the water maze).
Immunohistochemistry.
Half of the mice in each group (n = 5-6 per group) were deeply anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg) and transcardially perfused with ice-cold 0. Following placement in the center of the maze, a mouse had free access to all three arms.
Total arm entries and spontaneous alternation between arms was recorded for each testing day and compared between groups.
Water maze. A standard version of the water maze was used to assess spatial learning and reference memory beginning 120 DPI. During visible platform training, animals were placed in the pool at one of four start locations and given 60 seconds to locate a visible goal platform that was placed in a new location for each trial. After three days of training, the water level was increased two centimeters to "hide" the goal platform, which then remained in the same location for five days of memory testing. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Statistical analysis.
All statistical analysis was completed with GraphPad Prism 6.07 or IBS SPSS Statistics 24. A mixed model factorial analysis of variance (ANOVA) was used to evaluate group differences. ANOVA with repeated measures was used to classify group differences in behavioral tests. The between factors were genotype and injury and the within-group factor was day of testing. Main effects and interaction effects were considered. Two-tailed
Students t test was utilized for post-hoc comparison of the main effect(s) between B6 and hTau mice. t test with Welch's correction was incorporated to address comparisons in which the two samples had unequal variances or an unequal number of samples. Statistical significance was determined at p < 0.05. All data are presented as mean ± standard error of the mean (SEM).
Results
Microglial/Macrophage Response to TBI is Enhanced in hTau Mice at 3 DPI.
TBI induces a widespread neuroinflammatory response characterized by microglial reactivity, monocyte infiltration and increased production and release of inflammatory mediators. 19 CD45 is a type 1 transmembrane protein present on all hematopoietic cells that is upregulated in activated macrophages and expressed at lower levels in brain resident microglia. 28 Consistent with our previous findings, 25, 26 brain injury resulted in increased CD45 immunoreactivity near the injury site in B6 and hTau mice at 3 DPI (Fig.   1A ). Two-way ANOVA revealed a significant genotype effect and injury effect in the cortex lateral to the injury site. T test (with Welch's correction) confirmed that CD45 immunoreactivity was increased in hTau TBI mice compared to B6 TBI mice in the lateral cortex ( Fig. 1F) . A similar effect was detected in the ipsilateral hippocampus ( Fig. 1D ) with CD45 immunoreactivity significantly increased in hTau TBI mice compared to B6 TBI mice in the ipsilateral hippocampus (Fig. 1G ). These findings indicate that the presence of wildtype human tau significantly increases the acute microglial and macrophage response to TBI; however, the cell specific contribution to CD45 immunoreactivity could not be distinguished through immunohistochemistry. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Quantification of percent area covered by F4/80 immunohistochemistry supported the altered microglial/macrophage response in hTau TBI mice. F4/80 is a cell surface glycoprotein highly expressed on mouse macrophages. 29 Two-way ANOVA revealed a significant injury effect and interaction effect in the cortex lateral to the injury site (Fig.   1B ). hTau TBI mice displayed enhanced F4/80 immunoreactivity compared to B6 TBI mice;
however, a statistically significant genotype effect was not observed (Fig. 1F) . Similarly, two-way ANOVA revealed an injury effect in F4/80 immunoreactivity in the ipsilateral hippocampus ( Fig. 1E, 1G ).
Finally, CD68 immunoreactivity was used to identify macrophages, including microglia-derived macrophages responding to TBI or sham injury at 3 DPI. CD68 is a highly glycosylated transmembrane protein regarded as a potential marker for phagocytic activity in tissue macrophages. 30 Consistent with our previous results, 25 CD68 immunoreactivity was localized to the cortex at 3 DPI and not apparent in subcortical structures such as the hippocampus (Fig. 1C) . A significant effect of injury was detected with two-way ANOVA.
Consistent with CD45 and F4/80, hTau TBI mice displayed increased CD68 expression compared to B6 TBI mice (Fig. 1F) . Collectively, these data confirm that the microglial and/or macrophage response to brain injury is enhanced in hTau mice compared to B6 control mice.
TBI Induces Region Specific MAPT Phosphorylation in hTau Mice Compared to B6 Mice at 3 DPI.
To test whether enhancing microglial/macrophage reactivity in hTau mice promotes MAPT hyperphosphorylation, injured and sham brain tissue from B6 and hTau mice was immunostained with AT180 antibody. TBI and sham injury increased hyperphosphorylation at the phosphor-thr231 (AT180) epitope in the ipsilateral temporal cortex in hTau mice compared to B6 mice ( This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
TBI Promotes a Distinct Microglial/Macrophage Phenotype in hTau TBI Mice at 135 DPI.
To document the long-term consequences of TBI in hTau mice, separate groups of hTau and B6 mice received TBI or sham injury at two-months old and aged 135 DPI. CD45
immunoreactivity was variable within groups by 135 DPI and the rod-shaped morphology of CD45+ cells in TBI mice was less apparent compared to 3 DPI ( Fig. 2A) . Quantification of percent area covered by CD45 immunoreactivity in the cortex lateral to the site of injury verified no significant differences between groups (Fig. 2C ). CD45 immunoreactivity was not quantified in the ipsilateral hippocampus at 135 DPI due to low levels of detection;
however, several CD45+ cells were identified in the optic tract of brain injured mice.
Subsequent quantification of percent area covered by CD45 immunoreactivity in the optic tract revealed no significant differences between groups ( Fig. 2B-C ).
Mononuclear cells isolated from whole brains of TBI and sham injured B6 and hTau mice at 135 DPI were analyzed using flow-cytometry to distinguish populations of CD45 low/+ microglia and CD45 high peripheral lymphocytes and myeloid cells (Fig 3A) . 3B) . A third population of CD45 int microglia was identified, which expressed CD45 at levels that were higher than the CD11b low and CD11b high microglia (Fig 3B-C) . Thus, based on CD45 expression, we identified four, unique myeloid populations that persist under chronic injury conditions. The CD11b low microglia expressed the lowest levels of CD45, followed by the CD11b high and the CD45 int group characteristic of reactive microglia, while the peripheral macrophages were the highest expressers of CD45 (Fig 3C) .
Quantitation of microglial response revealed a significant reduction in the proportion of all three subpopulations in the hTau TBI group as compared to the B6 TBI cohort (Fig 3D) . No significant differences were seen in the proportions of CD11b+CD45 high cells (Fig 3F) . This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
changes the proportion of reactive microglia and macrophages within the brains of hTau mice compared to B6 mice.
Region Specific MAPT Pathology Persists in hTau TBI Mice at 135 DPI
Given the unique pattern of microglial and macrophage reactivity following TBI, we next examined the spatial distribution of MAPT pathology at 135 DPI in B6 and hTau mice.
Naïve hTau mice display age-associated MAPT pathology, beginning with somato-dendritic MAPT accumulation and hyperphosphorylation around 3-4 months of age and subsequent MAPT aggregation around 10 months of age. 15 Thus, we expected hTau sham and TBI mice to have some age-related MAPT pathology but predicted that it would be enhanced after brain injury. AT180 immunoreactivity was detected in all groups at 135 DPI and increased expression was notable in the cortex lateral to the site of injury as well as in the ipsilateral temporal cortex in hTau TBI mice ( Fig. 2D-E) . Two-way ANOVA of percent area covered by AT180 immunoreactivity revealed a significant genotype effect in the cortex lateral to the site of injury and in the ipsilateral temporal cortex (Fig. 2F) . AT180 immunoreactivity was highest in cortex lateral to the site of injury and in the ipsilateral temporal cortex in hTau TBI mice compared to all other groups. A significant difference in AT180 immunoreactivity was detected between B6 and hTau TBI mice in the ipsilateral temporal cortex, but no difference was detected between hTau TBI and hTau sham mice (Fig. 2F) . Together, these data indicate that MAPT phosphorylation occurs in a region dependent manner at a chronic post-injury time point following TBI in hTau mice.
To confirm and extend these results to determine if the hyperphosphorylated MAPT has acquired pre-tangle/NFT conformation, Gallyas silver staining was performed.
Gallyas silver staining is a standard detection method of MAPT pathology 31 and has been utilized by our group previously in hTau mice. 21 Strikingly, numerous Gallyas-positive neurons were identified in the CA1 region of the ipsilateral hippocampus in hTau TBI mice but not in age-matched B6 or hTau control mice (Fig. 2G) . Two-way ANOVA of relative number of Gallyas silver+ cells revealed a significant genotype, hemisphere and interaction effect in the hippocampus of TBI mice (Fig. 2G) This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
hippocampus of hTau TBI mice than B6 TBI mice. MAPT aggregates do not typically appear in hTau mice until around 9 months of age, thus these data suggest that a single TBI accelerates MAPT aggregation in hTau mice in a region dependent manner.
TBI Induces Spatial Memory Alterations in the Absence of Motor Dysfunction in hTau TBI
Mice.
Behavioral impairment has been reported at 12 months of age in naïve hTau mice, which is approximately 3 months after the first MAPT aggregates appear. No significant differences in spontaneous alternation between arms were detected between groups at any post-injury time (Fig. 4C) . Taken together, these data demonstrate that this severity of TBI does not induce global motor or cognitive deficits over time.
Water maze testing began 120 DPI. No significant differences in visible platform training were detected between groups. This finding indicated that visual deficiencies did not interfere with any subject's ability to learn the procedures of the task (i.e., swim to the platform and stay there for 15 seconds). Repeated measures ANOVA revealed a significant effect of testing day and injury group, p < 0.01. Neuman-Keuls multiple comparisons test indicated that latency to reach the submerged goal platform was significantly different between groups on memory testing day 1. hTau TBI mice took significantly longer to reach This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
the goal platform than B6 TBI and B6 sham mice, p < 0.05 (Fig. 4D) . The statistically significant difference between groups did not persist over time as all groups displayed decreased latency to reach the goal platform across testing days. No significant differences between groups were detected in average swim speed (Fig. 4E) or average time spent in the goal quadrant during probe testing (Fig. 4F) . Together, these data suggest that hTau TBI mice are deficient in acquiring the memory portion of this cognitive assessment.
Although statistically significant group differences did not persist across testing days, latency to reach the goal platform remained elevated in hTau TBI mice compared to other groups. This was not related to visual or motor deficits and did not prevent hTau TBI mice from completing the task.
In an effort to better characterize group differences that contributed to an acquisition deficit in memory testing, we evaluated search strategy to find the submerged goal platform as previously described. 27 Manual categorization of search strategy in each memory testing trial was completed by a single investigator blinded to injury group. Videos of each trial were replayed in Ethovision at 2x the speed, which resulted in a timely reanalysis of swim path. A single search strategy that best described the majority of swim path was noted for each trial. Three categories of swim path were considered, including spatial, non-spatial, and looping as previously defined (Fig. 5A) . 27 Briefly, spatial strategies included swimming directly to the platform (spatial direct), swimming toward the platform with only one loop (spatial indirect), and intentional searching within the goal quadrant (focal correct). Non-spatial strategies included searching the tank interior without spatial bias (scanning), searching the entire tank without spatial bias (random) and intentional searching of a portion of the tank that did not include the goal quadrant (focal incorrect).
Finally, looping strategies included circular swimming at a fixed distance from the wall (chaining), circling around the outer 15 cm of the pool including thigmotaxis (peripheral looping) and swimming in tight circles with directional movement (circling).
Percentage of trials using each search strategy as a function of injury group and day of hidden platform testing is displayed in Fig. 5B This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
larger percentage of trials in hTau mice compared to B6 mice, and use of looping strategies increased in hTau mice across testing days compared to B6 mice. This was most apparent on the last day of memory testing (day 5) when latency to reach the goal platform was similar between groups. For subsequent statistical analysis, average percentage of trials using each search strategy was calculated and compared between groups. Two-way ANOVA revealed a significant genotype effect for use of the spatial indirect search strategy, p < 0.05 (Fig. 5F ), scanning strategy, p = 0.05 (Fig. 5G) , and circling strategy, p < 0.05 (Fig. 5H ). Subsequent t tests revealed statistically significant differences between B6
and hTau TBI mice in scanning and circling strategies; however, significant differences were also detected between B6 TBI and hTau sham mice (p < 0.05) confirming a primary effect of genotype. A statistically significant difference is use of spatial indirect strategy was detected between B6 and hTau TBI mice, p < 0.01; however, no significant difference was observed between any other groups. Collectively, these data suggest that TBI in hTau mice compromises the use of spatial search strategies to complete a memory task. As a result the preferential use of non-spatial search strategies may have contributed to the acquisition deficit observed during memory testing.
Discussion
Increasing evidence supports the notion that a single TBI can alter the chronic neuroinflammatory environment; although few experimental studies extend beyond one year post-injury. For example, progressive cortical and hippocampal atrophy occurs in conjunction with reactive astrogliosis up to one year post-FPI in rats. 32 Similarly, glial expression of NF-B is observed in brain regions with persistent atrophy up to one year post-injury in the same model. 33 Even a single frontal mild TBI results in persistent deficits in attention, impulse control and decision making over 90 DPI that correlates with increased neuroinflammation in rodents. 34 These findings are consistent with human studies reporting increased mRNA expression of microglial markers OX-6 and CD68 at one This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
experimental studies have characterized the effects of TBI in various rodent models of AD in which genetic predisposition promotes the accumulation of beta-amyloid (Aβ) and MAPT pathology. Surprisingly and perhaps contrary to expected results, TBI does not significantly worsen chronic outcome in many of these models (see review 36 ) and has even diminished Aβ pathology in a few studies. 37, 38 Not until recently, have the neuromodulatory effects of accumulating Aβ emerged as an inflammatory stimuli in disease pathogenesis. 39 Previous work from our group demonstrates that the acute macrophage response to TBI is reduced in a genomic mouse model of AD (R1.40) prone to Aβ accumulation; however, the macrophage response persists in sub-cortical brain regions and coincides with chronic tissue loss and cognitive impairment up to 120 DPI. 25 A delayed neuroinflammatory response to TBI has also been reported by other groups examining a knock-in mouse model of AD (APP/PS1-KI). In agreement with our findings, APP/PS1-KI mice displayed a persistent neuroinflammatory response with significant cognitive impairment compared to controls. 40 We sought to extend these results by examining the neuromodulatory effects of pathogenic tau accumulation in a disease relevant mouse model of AD. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
In this model, two month old hTau and
to these cortical areas, 41 and may explain why hTau TBI mice display increased AT180 Finally, a battery of behavioral tests confirmed that the moderate severity of TBI utilized in these studies did not induce global deficits in motor or cognitive function through 135 DPI. Importantly though, hTau TBI mice displayed significantly longer latencies to reach the goal platform on day one of memory testing in the water maze compared to B6 sham and TBI mice. Although hTau TBI mice consistently took longer than all other groups to reach the goal platform throughout testing, no other significant differences were detected. A single probe trial was completed at the end of memory testing. During this trial, the platform is removed and animals are given 30 seconds to swim throughout the pool. Animals that have successfully learned the task spend more time in the goal quadrant than any other quadrant. The probe trial data did not support the notion that any group had displayed true spatial memory, as the average amount of time spent in the goal quadrant was around seven seconds. These data prompted us to consider how search strategy affected completion of the memory task. Based on previous reports, we predicted that a more effective search strategy would account for the mild performance differences between groups. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
the non-spatial scanning search strategy compared to other groups. hTau mice regardless of injury group also displayed increased use of looping strategies across five days of memory testing compared to B6 mice. Together, these data imply that hTau mice utilize non-spatial search strategies more frequently than B6 mice. Furthermore, TBI restricts the non-spatial search path to the center of the pool in hTau mice. Together, these data imply that TBI promotes the use of non-spatial search strategies in hTau mice which might account for longer latencies to reach the submerged goal platform. These results confirm that search strategy is complex and should be considered when analyzing data from the water maze memory task. Inclusion of swim path analysis may be particularly useful when it is difficult to identify the influence of cognitive, sensory or motor function on water maze performance. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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